H-1B Filings
38
DOL labor condition applications on file
Professional & Technical Services NJ
Novartis Pharmaceuticals CORPORATION — Workforce Profile
Federal-records workforce intelligence for Novartis Pharmaceuticals CORPORATION (NJ) — H-1B labor condition applications, OSHA injury and illness records, and WARN Act mass-layoff disclosures, fused into one transparent profile.
Median H-1B Salary
$145,670
Across 34 disclosed positions
OSHA Safety Grade
Grade A · DART 0.05
Industry avg DART 0.27
WARN Workforce Impact
36,390 workers
42 WARN Act notices on file
Government Data Summary
| Field | Value | Source |
|---|---|---|
| Employer Name | NOVARTIS PHARMACEUTICALS CORPORATION | DOL OFLC / OSHA / WARN |
| Industry | Professional & Technical Services | NAICS / DOL |
| State | NJ | U.S. Federal Records |
| H-1B Filings | 38 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $145,670 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | A | OSHA ITA |
| OSHA DART Rate | 0.05 | OSHA ITA Establishment Records |
| WARN Layoff Notices | 42 notice(s), 36,390 workers | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
Compiled from public records. Federal employer data is reported per OFFCP / EEOC compliance frameworks; values reflect the most recent disclosure period available.
H-1B Salary Data
| Job Title | Median |
|---|---|
| Executive Director, Forecasting | $241,592 |
| Director, AI Engineering | $223,642 |
| AD,Software Architect,Full Stack,RWD Sol | $187,741 |
| Associate Director, Web Platform Ops & Solutions Designs | $186,056 |
| Sr. Global Program Safety Lead | $183,186 |
| Associate Director, Product Adoption | $170,373 |
| Director, Integrated Analytics (Renal) | $170,373 |
| Associate Director, Business Performance | $169,541 |
| Director, Integrated Field Insights & Analytics | $169,541 |
| Director, BD&L, Insights and Decision Science | $169,541 |
| Sr. Principal AQS Tech & Scientific Com | $161,803 |
| Director, Medical Science Liaison | $161,138 |
| Associate Director, NPS Product Management | $158,974 |
| Associate Director Patient Marketing Vijoice | $156,894 |
| Senior Principal Biostatistician | $142,771 |
| R&D/Tech Dev Quality Lead, Compliance | $142,730 |
| Associate Director, Commercial Analytics | $141,170 |
| Associate Director, Product Management | $141,170 |
| Associate Director, Resource Optimization | $141,170 |
| Associate Director, Emerging Data Products | $139,506 |
| Principal Biostatistician | $133,904 |
| Associate Director, Business Applications Product Owner | $126,818 |
| Senior Manager, Functional Reporting | $126,818 |
| Associate Director Solution Delivery Clinical Analytics | $121,514 |
| Associate Director, PM QA | $118,435 |
| Expert Science & Technology | $114,109 |
| Director, US Forecasting | $111,966 |
| Senior Manager, PSC Operations Insights | $111,966 |
| Trial Vendor Senior Manager | $111,966 |
| Associate Director, Performance Reporting | $109,491 |
| Manager, Performance Reporting | $109,491 |
| Sr. Multi-Discipline Engineer | $107,952 |
| Sr Expert, Science & Technology (Drug Product-Product Lead) | $99,757 |
| Analyst, PSC Workforce Management | $94,557 |
What the Data Says About NOVARTIS PHARMACEUTICALS CORPORATION
NOVARTIS PHARMACEUTICALS CORPORATION operating in NJ within the Professional & Technical Services sector appears across multiple federal and state datasets that every job seeker, investigative reporter, and compliance researcher should know about. The company has filed 38 H-1B labor condition applications with a median disclosed wage of $145,670. Records here combine U.S. Department of Labor disclosures and state workforce agency filings. Each row on this page is sourced directly from a public government record, not a paid vendor or crowd-sourced review site, so the numbers reflect legally filed disclosures rather than opinion.
On workplace safety, NOVARTIS PHARMACEUTICALS CORPORATION posted a DART (Days Away, Restricted, Transferred) rate of 0.05 injuries per 100 full-time workers, compared with an industry peer average of 0.27. Our composite grade of "A" translates that raw rate into a relative benchmark so a job seeker can compare a hospital chain to a warehouse or a bank to a food processor without chasing down OSHA formulas. Across all years on file, OSHA logged 11 reportable injuries at this employer.
The layoff history is material here: 42 WARN Act notices affecting 36,390 workers have been filed against NOVARTIS PHARMACEUTICALS CORPORATION. The WARN Act requires 60 days of advance notice before mass layoffs or plant closings at employers with 100 or more workers, and those notices are filed publicly with state workforce agencies. A clustered pattern of notices often precedes earnings downgrades, bankruptcy filings, or private-equity-driven restructurings, so prospective employees should weigh this history alongside salary and safety data when evaluating an offer. Everything on this page is re-pulled each ETL cycle so stale disclosures don't linger and cross-portal links to industry and metro peers stay accurate.
OSHA Safety Record
Grade A DART Rate: 0.05 (Industry Avg: 0.27)
This employer DART rate (lower is safer)
Industry average
Days Away, Restricted, or Transferred rate per 100 full-time workers. Source: OSHA Injury & Illness data.
Total reported injuries on file: 11.
How Novartis Pharmaceuticals CORPORATION compares to Professional & Technical Services peers
Top H-1B-filing employers in the same NAICS sector. Peer cards link to their own federal-records profile.
NOVARTIS PHARMACEUTICALS CORPORATION
38 H-1B filings
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
5,182 H-1B filings
INFOSYS LIMITED
2,886 H-1B filings
WARN Act Layoff History
| Notice Date | Workers |
|---|---|
| 2023-08-01 | 1,030 |
| 2022-11-01 | 2,210 |
| 2021-06-01 | 1,860 |
| 2014-12-01 | 2,000 |
| 2014-04-01 | 470 |
| 2014-04-01 | 380 |
| 2014-04-01 | 380 |
| 2014-04-01 | 320 |
| 2014-04-01 | 150 |
| 2014-04-01 | 100 |
| 2014-04-01 | 90 |
| 2014-04-01 | 30 |
| 2014-04-01 | 20 |
| 2014-04-01 | 20 |
| 2014-04-01 | 20 |
| 2014-04-01 | 10 |
| 2014-04-01 | 10 |
| 2014-04-01 | 10 |
| 2014-04-01 | 10 |
| 2014-03-01 | 20 |
| 2014-02-01 | 20 |
| 2014-02-01 | 5,610 |
| 2014-02-01 | 230 |
| 2014-02-01 | 80 |
| 2014-02-01 | 80 |
| 2014-02-01 | 40 |
| 2014-02-01 | 40 |
| 2014-02-01 | 20 |
| 2014-02-01 | 40 |
| 2012-04-01 | 13,800 |
| 2012-04-01 | 930 |
| 2012-04-01 | 450 |
| 2012-04-01 | 350 |
| 2012-04-01 | 320 |
| 2012-04-01 | 270 |
| 2012-04-01 | 50 |
| 2012-03-01 | 50 |
| 2012-02-01 | 140 |
| 2012-02-01 | 2,470 |
| 2012-01-01 | 430 |
| 2011-11-01 | 1,450 |
| 2011-11-01 | 380 |
Related
Data sourced from official federal and state workforce datasets (DOL H-1B, OSHA ITA, state WARN notices). See our methodology for details. Retrieved and formatted by Kiznis Studio Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Learn more: Safety Grades Explained | H-1B Salary Negotiation
Read our methodology — how this data is sourced, computed, and verified.